EXACT Sciences Financial Statements
EXACT Sciences Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
EXACT Sciences Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | (0.9) | 1.8 | 4.8 |
| Gross Profit ($ mil.) | (0.9) | 1.7 | 3.9 |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (9.7) | (12.0) | (12.9) |
| Diluted EPS (Net Income) | (0.36) | (0.44) | (0.49) |
EXACT Sciences Quarterly Statements
| Quarter Ending Jun 09 | Quarter Ending Mar 09 | Quarter Ending Dec 08 | |
|---|---|---|---|
| Revenue ($ mil.) | 1.3 | 1.0 | (0.1) |
| Gross Profit ($ mil.) | 1.3 | -- | -- |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (2.4) | (3.8) | (2.1) |
| Diluted EPS (Net Income) | (0.08) | (0.13) | (0.08) |
EXACT Sciences Stock Quote & Chart
11/06/09 16:00:01 EST •
NASDAQ •
2.63
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
EXACT Sciences Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 51.02 | 7.55 | 7.01 |
| Price/Earnings Ratio | (6.67) | 93.46 | 25.51 |
| Price/Book Ratio | 13.39 | 3.48 | 6.74 |
| Price/Cash Flow Ratio | (6.92) | 41.49 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed EXACT Sciences Financial Ratios
EXACT Sciences Competitive Intelligence
| CRH Medical | PreMD | Radient Pharmaceuticals | |
|---|---|---|---|
| Annual Sales ($ mil.) | 6.7 | 0.1 | 28.3 |
| Employees | 37 | 10 | 500 |
| Market Cap ($ mil.) | 62.9 | 2.1 | 8.6 |
Competitive Landscape
